Breaking News Instant updates and real-time market news.

NVS

Novartis

$83.27

0.11 (0.13%)

05:36
07/18/17
07/18
05:36
07/18/17
05:36

Novartis backs FY17 revenue guidance of 'broadly in line with the prior year'

Novartis provided the following FY17 outlook: "We re-confirm our Group outlook as presented at the beginning of 2017. Group net sales in 2017 are expected to be broadly in line with the prior year, after absorbing the impact of generic competition, including the continued genericization of Gleevec/Glivec in the U.S. and Europe. From a divisional perspective, we expect net sales performance in 2017 to be as follows: Innovative Medicines: broadly in line with prior year, to a slight increase; Sandoz: broadly in line with prior year; Alcon: revised upward to low single digit growth. Group core operating income in 2017 is expected to be broadly in line with prior year to a low single digit decline. If mid-July exchange rates prevail for the remainder of 2017, the currency impact for the year would be negative 1 percentage point on net sales and negative 2 percentage points on core operating income."

  • 18

    Jul

NVS Novartis
$83.27

0.11 (0.13%)

07/14/17
LEER
07/14/17
NO CHANGE
Target $36
LEER
Outperform
Leerink sees significant optionality for AstraZeneca beyond MYSTIC trial
Leerink analyst Seamus Fernandez said he sees significant optionality for AstraZeneca (AZN) beyond the "mega-catalyst" of the MYSTIC trial in non-small cell lung cancer, as he believes several 2017 and 2018 readouts from underappreciated pipeline assets could lead to upside for the shares. If MYSTIC fails, Astra's "massive" SG&A spend gives it flexibility to mute the bottom-line impact. If it is successful, he believes potential acquirers such as Pfizer (PFE) or Novartis (NVS) could see "an attractive target to plunder," Fernandez tells investors. He keeps an Outperform rating and $36 price target on AstraZeneca ADRs.
07/13/17
SBSH
07/13/17
NO CHANGE
SBSH
Novartis vote bodes well for Kite and Juno, says at Citi
Citi analyst Robyn Karnauskas believes the FDA's unanimous vote in favor of Novartis' (NVS) CAR-T bodes well for Kite Pharma (KITE) and Juno Therapeutics (JUNO). Yesterday's panel meeting provides a preview of what Kite can expect ahead of its November 29 FDA action date, Karnauskas tells investors in a research note. She believes the expert commentary from the panel has "overarching implications" for Kite and Juno, both of which are developing CAR-T therapies for multiple indications.
07/12/17
RHCO
07/12/17
NO CHANGE
Target $108
RHCO
Buy
bluebird bio recent weakness unwarranted, says SunTrust
SunTrust analyst Edward Nash views the weakness in bluebird bio (BLUE) shares since the FDA briefing document on Novartis' (NVSR) CAR T product candidate as unwarranted. The tone of the briefing document is neutral and emphasizes short-term toxicities observed in Novartis' studies and long-term safety concerns so that the Advisory Committee will be able to conduct a thorough discussion to determine the risk/benefit ratio, Nash tells investors in a research note. Further, he believes the data from Novartis and bluebird are not an apples-to-apples comparison and reminds investors of the "differentiated safety profile" that bluebird's bb2121 has demonstrated to date. He recommends buying bluebird on the recent selloff and reiterates a Buy rating on the name with a $108 price target.
07/10/17
JEFF
07/10/17
NO CHANGE
Target $121
JEFF
Buy
Jefferies ups Kite target to $121 on 'relatively benign' FDA docs
Jefferies analyst Biren Amin raised his price target for Kite Pharma (KITE) shares to $121 from $101 after the FDA posted briefing documents ahead of the July 12 committee meeting disusing Novartis' (NVS) CAR-T therapy CTL019. The documents for the first CAR-T therapy seem "relatively benign," Amin tells investors in a research note. The FDA's view of CAR-T therapies looks in-line with expectations, but the agency may require long-term follow-up of patients to assess for risk of secondary malignancies, Amin writes. He keeps a Buy rating on Kite Pharma. The stock in late morning trading is down 3% to $102.55.

TODAY'S FREE FLY STORIES

TST

TheStreet

$1.80

(0.00%)

10:49
05/23/18
05/23
10:49
05/23/18
10:49
Hot Stocks
TheStreet announces content partnership with Symphony »

TheStreet, announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVOP

EVO Payments

$0.00

(0.00%)

10:48
05/23/18
05/23
10:48
05/23/18
10:48
Syndicate
Breaking Syndicate news story on EVO Payments »

EVO Payments opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$271.68

-0.89 (-0.33%)

10:47
05/23/18
05/23
10:47
05/23/18
10:47
Technical Analysis
Technical Take: Energy Select Sector SPDR falls after crude inventory data »

The Energy Select Sector…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$271.68

-0.89 (-0.33%)

XLE

Energy Select Sector SPDR

$77.03

-0.825 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCS

Communications Systems

$3.49

(0.00%)

10:47
05/23/18
05/23
10:47
05/23/18
10:47
Hot Stocks
Communications Systems forms special committee to explore strategic options »

Communications Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

10:45
05/23/18
05/23
10:45
05/23/18
10:45
General news
Breaking General news story  »

Week of 5/18 EIA…

GERN

Geron

$4.23

0.16 (3.93%)

10:40
05/23/18
05/23
10:40
05/23/18
10:40
Options
Repeat spread trading in Geron as shares rally »

Repeat spread trading in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$271.93

-0.64 (-0.23%)

10:35
05/23/18
05/23
10:35
05/23/18
10:35
Technical Analysis
Technical Take: SPDR S&P 500 ETF falls from highs after first hour »

At time of writing the…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$271.93

-0.64 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XGTI

xG Technology

$0.76

(0.00%)

10:35
05/23/18
05/23
10:35
05/23/18
10:35
Hot Stocks
xG Technology awarded $1.4M U.S. Air Force order »

xG Technology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTR

Frontier Communications

$9.05

-0.5 (-5.24%)

10:35
05/23/18
05/23
10:35
05/23/18
10:35
Options
Frontier Communications put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:33
05/23/18
05/23
10:33
05/23/18
10:33
General news
Crude inventories for week of May 18 »

Crude oil inventories…

QTNA

Quantenna Communications

$15.66

0.72 (4.82%)

, KOOL

Cesca Therapeutics

$0.54

0.0091 (1.71%)

10:33
05/23/18
05/23
10:33
05/23/18
10:33
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

QTNA

Quantenna Communications

$15.66

0.72 (4.82%)

KOOL

Cesca Therapeutics

$0.54

0.0091 (1.71%)

WTI

W&T Offshore

$8.26

-0.09 (-1.08%)

TAST

Carrols Restaurant

$11.70

0.05 (0.43%)

VNDA

Vanda Pharmaceuticals

$17.05

0.5 (3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

INTU

Intuit

$192.03

1.62 (0.85%)

, DSW

DSW

$24.95

-0.69 (-2.69%)

10:32
05/23/18
05/23
10:32
05/23/18
10:32
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

INTU

Intuit

$192.03

1.62 (0.85%)

DSW

DSW

$24.95

-0.69 (-2.69%)

SHAK

Shake Shack

$58.44

0.46 (0.79%)

LTC

LTC Properties

$39.13

-0.32 (-0.81%)

CELG

Celgene

$77.24

0.65 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 03

    Jun

  • 05

    Jun

  • 12

    Jun

  • 13

    Jun

AEE

Ameren

$57.59

0.87 (1.53%)

, GDS

GDS Holdings

$38.91

1.53 (4.09%)

10:32
05/23/18
05/23
10:32
05/23/18
10:32
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

AEE

Ameren

$57.59

0.87 (1.53%)

GDS

GDS Holdings

$38.91

1.53 (4.09%)

JWN

Nordstrom

$47.30

1.51 (3.30%)

FCX

Freeport McMoRan

$16.98

-0.19 (-1.11%)

CELG

Celgene

$77.24

0.65 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

  • 05

    Jun

  • 13

    Jun

GSHD

Goosehead Insurance

$16.30

0.26 (1.62%)

10:32
05/23/18
05/23
10:32
05/23/18
10:32
Hot Stocks
Goosehead Insurance plans to open corporate office in Chicago »

Personal lines insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$128.43

-0.84 (-0.65%)

10:26
05/23/18
05/23
10:26
05/23/18
10:26
Downgrade
Nordson rating change  »

Nordson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

CELG

Celgene

$77.35

0.76 (0.99%)

10:24
05/23/18
05/23
10:24
05/23/18
10:24
Hot Stocks
Street Fight: Argus sees Celgene risk, but Bernstein thinks sentiment at bottom »

In a research note this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 03

    Jun

  • 05

    Jun

  • 13

    Jun

EVOP

EVO Payments

$0.00

(0.00%)

10:21
05/23/18
05/23
10:21
05/23/18
10:21
Syndicate
Breaking Syndicate news story on EVO Payments »

EVO Payments indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

MRK

Merck

$59.07

0.61 (1.04%)

10:20
05/23/18
05/23
10:20
05/23/18
10:20
Options
Short term call buyers in Merck lead puts 8:1 »

Short term call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

  • 23

    Oct

CWH

Camping World

$20.09

-1.31 (-6.12%)

10:18
05/23/18
05/23
10:18
05/23/18
10:18
Hot Stocks
Camping World slides after reporting change in registered public accounting firm »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVOP

EVO Payments

$0.00

(0.00%)

10:17
05/23/18
05/23
10:17
05/23/18
10:17
Syndicate
EVO Payments indicated to open at $20.80, IPO priced at $16.00 »

EVO Payments (EVOP)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
05/23/18
05/23
10:17
05/23/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
05/23/18
05/23
10:16
05/23/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CWH

Camping World

$20.20

-1.2 (-5.61%)

10:13
05/23/18
05/23
10:13
05/23/18
10:13
Hot Stocks
Camping World slides after reporting change in registered public accounting firm »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

$15.97

0.03 (0.19%)

10:10
05/23/18
05/23
10:10
05/23/18
10:10
Options
Bullish option flow in Kinder Morgan »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$36.41

0.04 (0.11%)

10:05
05/23/18
05/23
10:05
05/23/18
10:05
Options
JD.com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.